Across
- 4. Cardioselective beta-1 blocker; used in HFrEF and hypertension
- 7. Elevated intraocular pressure; optic nerve damage; gradual visual field loss; eye drops
- 8. Overnight sleep study; gold standard for diagnosing sleep apnea and REM disorders
- 9. Breast cancer imaging screening; decisions individualized in elderly based on life expectancy
- 12. Dopamine precursor; primary treatment for motor symptoms of Parkinsons disease
- 13. Hormone required for type 1 DM and advanced type 2; hypoglycemia risk in elderly
- 16. Mini-Mental State Examination; score less than 24 suggests dementia
- 20. T-score of negative 2.5 or less on DEXA; each SD below peak bone mass doubles fracture risk
- 21. Aldosterone antagonist; used in HFrEF alongside ACE inhibitor and beta-blocker
- 23. Geriatric syndrome of diminished physiological reserve; defined by Frieds 5-criterion phenotype
- 26. Mood stabilizer; narrow therapeutic index; renal clearance decreases with age; toxicity risk
- 28. Anticonvulsant used for neuropathic pain; dose-reduce in renal impairment
- 30. Tremor bradykinesia rigidity; can be drug-induced by antipsychotics and metoclopramide
- 31. Montreal Cognitive Assessment; more sensitive than MMSE for MCI detection
- 33. Dual-Energy X-ray Absorptiometry; gold standard bone mineral density scan
- 34. Mild Cognitive Impairment; cognitive decline without ADL impairment; precursor to dementia
- 35. Loop diuretic; first-line for acute decompensated heart failure and volume overload
- 36. Pulmonary function test; FEV1 over FVC less than 0.70 confirms COPD diagnosis
- 39. Most common sustained arrhythmia requiring anticoagulation; fibrillation
- 41. Antimuscarinic for overactive bladder; high anticholinergic burden; Beers Criteria PIM
- 47. First-line analgesic in elderly; safer than NSAIDs; max 2-3g per day in elderly
- 48. Short-acting benzodiazepine; Beers Criteria PIM; high fall and delirium risk in elderly
- 49. Acute confusion; CAM criteria: acute onset inattention disorganized thinking or altered consciousness
- 53. Weekly oral bisphosphonate; first-line treatment for osteoporosis
- 55. Monosodium urate crystal arthritis; acute attacks in great toe; treated with colchicine
- 56. Annual IV bisphosphonate for osteoporosis; convenient for adherence
- 57. HMG-CoA reductase inhibitors; first-line for hyperlipidemia; myopathy risk in elderly
- 58. Magnetic Resonance Imaging; best modality for early osteomyelitis and soft tissue detail
- 61. NMDA receptor antagonist; indicated for moderate-to-severe Alzheimers disease
- 63. Impaired coordination and balance; cerebellar sign; seen in NPH and drug toxicity
- 64. Muscle breakdown with myoglobinuria; statin complication; elevated CK; renal failure risk
- 66. Gold standard colorectal cancer screening; every 10 years from age 50; needs bowel prep
Down
- 1. Bladder function testing; measures detrusor pressure and flow; diagnoses incontinence type
- 2. First-line oral antidiabetic; reduces hepatic glucose production; hold if eGFR less than 30
- 3. Long-acting benzodiazepine; Beers Criteria PIM; accumulates in elderly due to high Vd
- 5. Proton pump inhibitor; reduces GI risk with NSAIDs; long-term use reduces B12 and magnesium
- 6. Dihydropyridine calcium channel blocker; first-line for isolated systolic hypertension in elderly
- 10. ADP receptor antagonist antiplatelet; used post-MI and post-stroke; pairs with aspirin
- 11. NPH triad: gait disturbance cognitive decline urinary incontinence; LP-responsive
- 14. Atypical antipsychotic; black box warning for dementia-related psychosis; BPSD
- 15. Protein misfolding disorder; AL or AA type; causes restrictive cardiomyopathy and neuropathy
- 17. Vitamin K antagonist anticoagulant; requires INR monitoring; high fall risk in elderly
- 18. Continuous 24-48hr ECG monitor; used to detect arrhythmias causing syncope
- 19. Ultrasound of the heart; evaluates ejection fraction; key in heart failure workup
- 22. Most common arthritis; cartilage degeneration; Heberden nodes at DIP joints; no DMARDs
- 23. WHO fracture risk tool; calculates 10-year probability of major osteoporotic fracture
- 24. Serum protein; reduced in malnutrition; increases free drug concentrations in elderly
- 25. Table test used to reproduce and diagnose vasovagal syncope
- 27. Opioid contraindicated in elderly; normeperidine metabolite causes seizures
- 29. Bone mineral measurement technique used in DEXA scanning
- 32. SSRI antidepressant; first-line for late-life depression; QTc prolongation risk
- 37. Timed Up and Go test; greater than 12 seconds indicates high fall risk in elderly
- 38. Proximal muscle pain and stiffness; ESR elevated; responds to steroids; rheumatica
- 40. Low thyroid hormone; treated with levothyroxine; start at low dose 25-50 mcg in elderly
- 42. Brain Natriuretic Peptide; elevated in heart failure; guides diagnosis and management
- 43. Peripheral nerve damage; common diabetic complication; burning and numbness in hands and feet
- 44. ACE inhibitor; first-line for HFrEF diabetic nephropathy and post-MI
- 45. Cholinesterase inhibitor; first-line drug for mild-to-moderate Alzheimers disease
- 46. Alpha-1 blocker for BPH; reduces urinary obstruction; causes orthostatic hypotension
- 50. International Normalized Ratio; monitors warfarin therapy; target 2-3 for AF
- 51. Prostate-Specific Antigen; screening test for prostate cancer; individualize in elderly
- 52. Progressive cognitive decline impairing daily function; Alzheimers most common type
- 54. Cardiac glycoside; used for rate control in AF; narrow therapeutic index; toxic in renal impairment
- 59. Excessive bone remodeling disease; elevated alkaline phosphatase
- 60. Thyroid Stimulating Hormone; most sensitive test for thyroid dysfunction
- 62. Electrocardiogram; first test in syncope workup; detects arrhythmia and ischemia
- 65. Non-invasive vascular imaging ultrasound for DVT and carotid artery stenosis
